ATM and colorectal carcinoma: The CCK8 assay was used to quantify the viability of various human CRC cell lines (SK-CO-1, SW480, RKO, HCT116, and SW620) treated with BMN673 and substantiate the antitumor efficacy of BMN673 in ATM-deficient CRC.